[16] [18] During lactation, ascorbic acid is excreted in breast milk, and excessive maternal intake could theoretically affect the infant
OX472 GLP-1 agonist, semaglutide OX472 is an innovative intranasal formulation of semaglutide, a GLP-1 receptor agonist, developed using Orexos proprietary AmorphOX technology
An injection is given once weekly Rybelsus- tablet given once daily Exenatide: It is sold as Byetta is injected twice daily Bydureon injected once a week Liraglutide: the available brands are Victoza is used to treat Type 2 DM Saxenda used to manage chronic weight management Dulaglutide: It is marketed as Trulicity
Delivered as a nasal spray, oxytocin allows for rapid absorption through the nasal mucosa, supporting both central (brain-mediated) and systemic effects without the need for injections
The strongest risk occurred within the first year of treatment That timing may suggest an association between the drug and the sudden onset of optic nerve injury, though a retrospective cohort design cannot establish a definite causation
(NIDDK) How do GLP-1 medications help with blood sugar